Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis

Background Despite the increasingly prevalent role of platelet glycoprotein (GP) IIb/IIIa receptor inhibitors in acute coronary syndromes and percutaneous coronary interventions, the incidence and clinical relevance of thrombocytopenia occurring with their use remain unclear. Methods We identified 8...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2000-08, Vol.140 (2), p.206-211
Hauptverfasser:	Dasgupta, Himadri, Blankenship, James C., Wood, G.Craig, Frey, Carolin M., Demko, S.Lee, Menapace, Francis J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abciximab Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Biological and medical sciences Drug toxicity and drugs side effects treatment Eptifibatide Hemorrhage - blood Hemorrhage - chemically induced Humans Immunoglobulin Fab Fragments - adverse effects Immunoglobulin Fab Fragments - therapeutic use Medical sciences Peptides - adverse effects Peptides - therapeutic use Pharmacology. Drug treatments Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Randomized Controlled Trials as Topic Thrombocytopenia - blood Thrombocytopenia - chemically induced Tirofiban Toxicity: blood Tyrosine - adverse effects Tyrosine - analogs & derivatives Tyrosine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!